Cardiovascular Benefit for Weekend Warriors the Same as Regular Exercisers
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, July 18, 2023 -- Physical activity concentrated within a few days is associated with a similarly lower risk for cardiovascular outcomes as more evenly distributed activity, according to a study published in the July 18 issue of the Journal of the American Medical Association.
Shaan Khurshid, M.D., M.P.H., from Massachusetts General Hospital in Boston, and colleagues examined associations between an accelerometer-derived "weekend warrior" pattern (most moderate-to-vigorous physical activity [MVPA] achieved over one to two days) versus MVPA spread more evenly with the risk for incident cardiovascular events. The analysis included data from 89,573 individuals with accelerometer data.
The researchers found that both activity patterns were associated with similarly lower risks for incident atrial fibrillation (active weekend warrior: hazard ratio, 0.78; 95 percent confidence interval, 0.74 to 0.83; active regular: hazard ratio, 0.81; 95 percent confidence interval, 0.74 to 0.88) versus inactivity (hazard ratio, 1.00; 95 percent confidence interval, 0.94 to 1.07). Similar results were seen for myocardial infarction, heart failure, and stroke. For the median threshold of ≥230.4 minutes of MVPA per week, associations were consistent, although associations were no longer significant with stroke.
"Increased activity, even when concentrated within one to two days each week, may be effective for improving cardiovascular risk profiles," the authors write.
One study author disclosed ties to industry.
Viewpoint (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.